Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

LIVE MARKETS-STOXX in the red, banks in the black

Mon, 30th Dec 2019 08:50

Welcome to the home for real-time coverage of European equity markets brought to you by Reuters
stocks reporters and anchored today by Julien Ponthus. Reach him on Messenger to share your
thoughts on market moves: julien.ponthus.thomsonreuters.com@reuters.net

STOXX IN THE RED, BANKS IN THE BLACK (0843 GMT)

As expected, the open was not particularly inspiring. About half an hour into trading, the
STOXX 600 is down 0.25% with most regional bourses slightly in the red.

Most sectors are in negative territory with the exception of banks, which are up nearly
0.1%.

Granted, European lenders are 2019 laggards with a YTD rise of less than 9% against 24% for
the STOXX 600 - so this ain't exactly playing catch-up.

There aren't really any wild moves either among individual stocks, though shares in
EssilorLuxottica are down 2% after the company said it had discovered fraudulent activity at a
plant in Thailand.

Here are Europe's benchmarks at 0843 GMT:

(Julien Ponthus)

*****

NO SPARKS EXPECTED AT THE OPEN (0742 GMT)

European futures are trading just slightly in the red, pointing to a roughly negative to
flat open after last week’s record highs. No sign so far that the bullishness which has propped
up Asian bourses overnight will spill over here.

It’s very quiet on the corporate front with a few exceptions, notably EssilorLuxottica which
said it discovered fraudulent financial activity at a plant in Thailand.

In Germany, Daimler’s CEO told Bild am Sonntag that his group was targeting a reduction in
personnel costs by 1.4 billion euros by end-2022 and Lufthansa failed to avert a planned cabin
crew strike at Germanwings.

Also, AstraZeneca and Merck & Co got a drug approved for the treatment of pancreatic cancer
in the U.S.

(Julien Ponthus)

*****

(Reporting by Danilo Masoni, Joice Alves, Julien Ponthus and Thyagaraju Adinarayan)

Related Shares

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsort...

3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out...

2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for pr...

2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood canc...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.